To advance the clinical development of its medical device for the specific extraction of toxic free metals from the blood, MexBrain has announced the raising of 5.75 million euros. This round of financing brings together two institutional investors, Arbevel and Kreaxi, as well as the French Tech Seed fund operated on behalf of the French government by Bpifrance within the framework of the Future Investment Program (PIA), which is making its first equity investment, and private investors gathered around Buffavent Holding and Angelor.
